Conference call and webcast to begin at 1:30 p.m. PT (4:30 p.m. ET)
IRVINE, Calif.--(BUSINESS WIRE)--Jan. 29, 2016--
Masimo (NASDAQ: MASI) announced today that it will release financial
results for the fourth quarter ended January 2, 2016, after the market
closes on Tuesday, February 23, 2016. The conference call to review the
results will begin at 1:30 p.m. PT (4:30 p.m. ET) and will be hosted by
Joe Kiani, Chairman and Chief Executive Officer, and Mark P. de Raad,
Executive Vice President and Chief Financial Officer.
A live webcast of the conference call will be available online from the
investor relations page of the company's corporate website at www.masimo.com.
The dial-in numbers are (888) 520-7182 for domestic callers and +1 (706)
758-3929 for international callers. The reservation code for both
dial-in numbers is 40429223. After the live webcast, the call will be
available on Masimo's website through March 22, 2016. In addition, a
telephonic replay of the call will be available through March 8, 2016.
The replay dial-in numbers are (855) 859-2056 for domestic callers and
+1 (404) 537-3406 for international callers. Please use reservation code
40429223.
About Masimo
Masimo (NASDAQ: MASI) is a global leader in innovative noninvasive
monitoring technologies. Our mission is to improve patient outcomes and
reduce the cost of care by taking noninvasive monitoring to new sites
and applications. In 1995, the company debuted Masimo SET®
Measure-through Motion and Low Perfusion™ pulse oximetry, which has been
shown in multiple studies to significantly reduce false alarms and
accurately monitor for true alarms. The benefits of Masimo SET® have
been proven in more than 100 independent and objective studies and it is
estimated to be used on more than 100 million patients in leading
hospitals and other healthcare settings around the world. In 2005,
Masimo introduced rainbow® Pulse CO-Oximetry technology, allowing
noninvasive and continuous monitoring of blood constituents that
previously could only be measured invasively, including total hemoglobin
(SpHb®), oxygen content (SpOC™), carboxyhemoglobin (SpCO®),
methemoglobin (SpMet®), and more recently, Pleth Variability Index
(PVI®) and Oxygen Reserve Index (ORI™), in addition to SpO2, pulse rate,
and perfusion index (PI). In 2014, Masimo introduced Root®, an intuitive
open architecture patient monitoring and connectivity platform designed
to speed the pace of innovation and reduce the cost of care. Masimo is
also taking an active leadership role in mHealth with products such as
the Radius-7™ wearable patient monitor and the MightySat™ fingertip
pulse oximeter. Additional information about Masimo and its products may
be found at www.masimo.com.
Masimo, SET, Signal Extraction Technology, Improving Patient Outcome
and Reducing Cost of Care by Taking Noninvasive Monitoring to New Sites
and Applications, rainbow, SpHb, SpOC, SpCO, SpMet, PVI are trademarks
or registered trademarks of Masimo.
View source version on businesswire.com: http://www.businesswire.com/news/home/20160129005020/en/
Source: Masimo
Masimo
Investor Contact:
Eli Kammerman, (949) 297-7077
ekammerman@masimo.com
or
Media
Contact:
Irene Paigah, (858) 858-7001
irenep@masimo.com